Cigna Corp (CI)
Days of sales outstanding (DSO)
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receivables turnover | 11.02 | 9.95 | 10.15 | 10.34 | 10.48 | 10.45 | 9.81 | 11.07 | 11.55 | 10.47 | 10.79 | 11.99 | 13.16 | 11.64 | 12.17 | 13.13 | 14.33 | 11.06 | |||
DSO | days | 33.13 | 36.68 | 35.95 | 35.31 | 34.81 | 34.94 | 37.20 | 32.98 | 31.60 | 34.87 | 33.84 | 30.45 | 27.74 | 31.37 | 29.98 | 27.80 | 25.47 | 33.00 |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 11.02
= 33.13
The days of sales outstanding (DSO) for Cigna Group (The) has shown some fluctuations over the past eight quarters. In Q4 2023, the DSO decreased to 33.13 days compared to the previous quarter where it was at 46.13 days. This indicates a more efficient collection of accounts receivable in the most recent quarter.
Looking at a longer trend, compared to the same quarter in the previous year (Q4 2022), the DSO has decreased significantly from 34.81 days to 33.13 days, pointing towards an improvement in the company's ability to collect payments from customers in a timely manner.
Overall, the downward trend in DSO over the quarters signifies better management of accounts receivable and a potential increase in liquidity for Cigna Group (The).
Peer comparison
Dec 31, 2023
See also:
Cigna Corp Average Receivable Collection Period (Quarterly Data)